Mediera (ROCO:5398) EBIT per Share : NT$0.06 (TTM As of Mar. 2025)

View and export this data going back to 1999. Start your Free Trial

What is Mediera EBIT per Share?

Mediera's EBIT per Share for the three months ended in Mar. 2025 was NT$-0.24. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2025 was NT$0.06.

During the past 3 years, the average EBIT per Share Growth Rate was -35.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Mediera's EBIT per Share or its related term are showing as below:

ROCO:5398' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -145 Med: -23.7 Max: 31.7
Current: -35

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Mediera was 31.70% per year. The lowest was -145.00% per year. And the median was -23.70% per year.

ROCO:5398's 3-Year EBIT Growth Rate is ranked worse than
90.38% of 832 companies
in the Drug Manufacturers industry
Industry Median: 8.65 vs ROCO:5398: -35.00

Mediera's EBIT for the three months ended in Mar. 2025 was NT$-12.0 Mil.

Mediera EBIT per Share Historical Data

The historical data trend for Mediera's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mediera EBIT per Share Chart

Mediera Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EBIT per Share

Get a 7-Day Free Trial

0.36

0.42

-0.09

-0.61

0.34

Mediera Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EBIT per Share	Get a 7-Day Free Trial															0.03	0.19	0.10	0.02	-0.24

Mediera EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Mediera's EBIT per Share for the fiscal year that ended in Dec. 2024 is calculated as

	EBIT per Share		(A: Dec. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	16.786	/	49.465
=	0.34

Mediera's EBIT per Share for the quarter that ended in Mar. 2025 is calculated as

	EBIT per Share		(Q: Mar. 2025 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-12.033	/	49.465
=	-0.24

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.06

Mediera (ROCO:5398) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Mediera EBIT per Share Related Terms

Thank you for viewing the detailed overview of Mediera's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Mediera Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mediera Corp (ROCO:5398) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 239 Datong Road, Section 1, 16th Floor, Xizhi District, New Taipei, TWN

Website

http://www.mediera.com.tw

Mediera Corp is engaged in domestic research and development, production and manufacturing of various power supply components, and launched its own brand. MEDIERA is also committed to the production of customized products and OEM. It has been more active in the transformation and layout of the development of medical biotechnology. For example, medicines, healthy foods, and medical equipment that greatly help human health have become the focus of development in recent years. In addition, combined with the scientific and technological research and development capabilities of the Electronics Division, advanced The application of electronic micro-control patented technology in electronic medical equipment that can help patients improve their quality of life is a major breakthrough for company.

Mediera Headlines

No Headlines